[In the afternoon of the first day of the 2026 National Talks: Pfizer, Innovent Biologics and many other Chinese and foreign companies entered the venue] "Science and Technology Innovation Board Daily" reported on the 5th that the negotiations on the 2026 National Medical Insurance Catalog officially started today. A reporter from "Science and Technology Innovation Board" learned at the scene that at about 1:15 p.m., people entered the venue Companies include Hengrui Pharmaceuticals, Dongguang Pharmaceutical, Zhuhai Rundu Pharmaceuticals, CSPC Pharmaceutical Group, Shanghai Pharmaceuticals, Innovent Biologics, Jingxin Pharmaceuticals, Boehringer Ingelheim, Novo Nordisk, Pfizer, etc. Companies entering the market this morning include Genting Xinyao, Zai Lab, 3SBio, Joincare, Kangyuan Pharmaceuticals, etc. (Kechuangban Daily reporter Shi Shiyun)